G

00874

Guangzhou Baiyunshan Pharmaceuti…

18.32

0.04+0.22%
Opening11:31 11/01 HKT
1D
5D
Daily
Weekly
Monthly
Quarterly
Yearly
OPEN/PREV CLOSE18.200/18.280
TODAY RANGE18.200-18.560
VOL2.06M
MARKET CAP29.78B
52 WEEK RANGE16.620-24.200
AVG VOL (3M)1.52M
% TURNOVER0.13%
TURNOVER37.74M
P/E (TTM)7.846
% RANGE1.97%
EPS(TTM)2.335
P/E(FORWARD)7.439
P/B0.742
BVPS24.706
DIVIDEND0.823
P/S0.332
BETA--
DIV YIELD4.49%
FREE FLOAT MKT CAP4.03B
SHARES OUTSTANDING1.63B
NEXT EARNINGS--
FREE FLOAT219.90M
LOT SIZE2000
EX-DIV DATE06/13/2024
Feeds
News
Press Releases
Financial Reports
Profile
Same Industry
Name/Symbol
Change%
Price

G

Guangzhou Baiyunshan Pharmaceutical Holdings

00874

+0.22%
18.320

A

Amgen

04332

--

W

Wuxi Apptec

02359

+0.10%
51.750

C

China Conch Venture Holdings

00586

+0.28%
7.240

A

Asymchem Laboratories (Tianjin)

06821

+0.97%
57.000

S

Sinopharm Group

01099

+0.83%
19.500

L

Livzon Pharmaceutical Group

01513

+2.10%
26.700

S

Shanghai Pharmaceuticals Holding

02607

+1.83%
12.220

S

Shanghai Fosun Pharmaceutical (Group)

02196

+0.68%
14.900

C

China Medical System Holdings

00867

+1.03%
7.870

S

SciClone Pharmaceuticals (Holdings)

06600

0.00%
18.720

C

China Isotope & Radiation

01763

+0.71%
11.360

W

Wuxi Biologics (Cayman)

02269

+0.98%
16.500

C

China Shineway Pharmaceutical Group

02877

+1.41%
9.330

T

The United Laboratories International Holdings

03933

-0.19%
10.540

C

Consun Pharmaceutical Group

01681

+2.78%
8.500

3

3SBio

01530

+0.69%
5.870

S

Shandong Xinhua Pharmaceutical

00719

+0.34%
5.920

B

Beijing Tong Ren Tang Chinese Medicine

03613

+1.60%
8.260

C

China Resources Pharmaceutical Group

03320

+0.73%
5.540

C

CSPC Pharmaceutical Group

01093

-8.70%
5.250
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.